Matches in Nanopublications for { ?s ?p "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 11 of
11
with 100 items per page.
- NP651421.RAfF8CGPCSKmUh75lmprCM_Et8kFCUmXYGUaxljoSV7u4130_assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651421.RAfF8CGPCSKmUh75lmprCM_Et8kFCUmXYGUaxljoSV7u4130_provenance.
- NP413368.RAZeD4Wu9mOPYl85FKEE1kXVvNFXgNEmT4DOtPbj697s4130_assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP413368.RAZeD4Wu9mOPYl85FKEE1kXVvNFXgNEmT4DOtPbj697s4130_provenance.
- NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP613712.RAgrzmztQ3fFSs71W12qadBpo2WsMRM0D_04vuNT1EuN0130_provenance.
- NP547474.RAx6QCucAOToC9WHdCTwZoClGbgyLWSIli39oJLRfIF0Y130_assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP547474.RAx6QCucAOToC9WHdCTwZoClGbgyLWSIli39oJLRfIF0Y130_provenance.
- NP294176.RA-VMWXCWxDMw42CzkF2exXErWKHZzlVLWkblRslBNaNg130_assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP294176.RA-VMWXCWxDMw42CzkF2exXErWKHZzlVLWkblRslBNaNg130_provenance.
- NP537701.RANvAw6EsXkeUxcA4ltvkYvhLxXgBbdSCqGmqEV3lVst8130_assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP537701.RANvAw6EsXkeUxcA4ltvkYvhLxXgBbdSCqGmqEV3lVst8130_provenance.
- NP571910.RAP3VDuWaL2wWJFLvv_8b-0Jvb6Z7irZeu4I8jVy3xFUU130_assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP571910.RAP3VDuWaL2wWJFLvv_8b-0Jvb6Z7irZeu4I8jVy3xFUU130_provenance.
- NP579182.RAFpxZAdj8Ri2xJRU2xC2M5w3aFdaEq4Rstk8ynVpq9AU130_assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP579182.RAFpxZAdj8Ri2xJRU2xC2M5w3aFdaEq4Rstk8ynVpq9AU130_provenance.
- assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP519508.RAa5ObwyIPg6lu8CKquiDzJy5OdAry4Lrul5dWJ0KOODQ130_assertion description "[We evaluate whether molecular monitoring of minimal residual disease (MRD) using TCR delta (TCRD), TCR gamma (TCRG), and immunoglobulin H (IgH) gene rearrangements in the bone marrow (BM) is correlated with clinical events in ALL patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP519508.RAa5ObwyIPg6lu8CKquiDzJy5OdAry4Lrul5dWJ0KOODQ130_provenance.